Cipher Pharmaceuticals Inc.
CPHR
CPHR was delisted on the 8th of December, 2016.
0 hedge funds and large institutions have $0 invested in Cipher Pharmaceuticals Inc. in 2017 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $8.53M → $0 (-$8.53M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$8.53M |
CPHR Hedge Fund Activity: Q3 2017 in Review
0 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q3 2017, worth a combined $0 — down 100% from $8.53M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CPHR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Grandeur Peak Global Advisors, exiting entirely with an estimated $8.53M sold.
- 0 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q3 2017, down from 1 in Q2 2017.
- Funds reported $0 of Cipher Pharmaceuticals Inc. stock for Q3 2017, down 100% quarter-over-quarter.
- 0 funds opened new Cipher Pharmaceuticals Inc. positions in Q3 2017 and 1 closed out, a net change of -1 holder.
- The largest Cipher Pharmaceuticals Inc. seller in Q3 2017 was Grandeur Peak Global Advisors, an estimated $8.53M sold.
Based on aggregated 13F filings for Q3 2017.